Article

On the Web: Neuropathy Resources

Conducting online research can be overwhelming. CURE makes it quick & easy by providing links to the best information from organizations we trust.

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of certain anti-cancer treatments. How these drugs affect the nerves differs depending on the amount of the drug used, the treatment schedule, the patient’s age and pre-existing issues that can put the patient at risk.

Conducting online research can be overwhelming. CURE makes it quick & easy by providing links to the best neuropathy information from organizations we trust.

CURE articles:

> "Lessons Learned: Peripheral Neuropathy from Cancer" at curetoday.com When trying to cope with peripheral neuropathy, sufferers could benefit from others’ success.

> "Numbing Down Neuropathy" at curetoday.com

Research and awareness help patients to understanding and manage chemotherapy-related peripheral neuropathy.

> "Tingling Troubles" at curetoday.com

Causes, prevention and management of peripheral neuropathy.

Other trusted resources:

> American Cancer Society on Neuropathy at cancer.org

> The Foundation for Peripheral Neuropathy> The Mayo Clinic at mayoclinic.org.

> The National Comprehensive Cancer Network’s “Management of Neuropathy in Cancer” at nccn.org

> The Neuropathy Support Network at neuropathysupportnetwork.org

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Related Content